DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Valiant Laboratories Limited (VALIANTLAB) share price today?

Valiant Laboratories Limited (VALIANTLAB) is trading at ₹134.65 on the NSE, up 5.00% on the day. Source: DocStoX.

What is the PE ratio of Valiant Laboratories Limited?

Valiant Laboratories Limited has a price-to-earnings (PE) ratio of 42.3 in the Healthcare sector.

What is the market capitalisation of Valiant Laboratories Limited?

Valiant Laboratories Limited has a market capitalisation of approximately ₹731 crore.

Is Valiant Laboratories Limited a profitable company?

Valiant Laboratories Limited generates a return on equity of -1.1% with a net profit margin of -1.4%. That is a modest return on shareholder capital.

What is the 52-week high and low of VALIANTLAB?

Valiant Laboratories Limited (VALIANTLAB) has traded between ₹49.51 and ₹134.65 over the past 52 weeks, against a current price of ₹134.65.

Valiant Laboratories Limited

₹134.65▲ +6.41 (+5.00%)

VALIANTLAB·NSE·Healthcare

Market Cap

731.05 Cr

PE Ratio

42.30

Volume

1,04,508

Day High - Low

134.65 - 125.25

52W High-Low

134.65 - 49.51

₹134.65▲ +6.41 (+5.00%)

Market Cap731.05 Cr

PE Ratio42.30

Volume1,04,508

Day High - Low134.65 - 125.25

52W High-Low134.65 - 49.51

Valiant Laboratories Limited (VALIANTLAB): company summary

The company's annual revenue rose 78.5% year-over-year, but net profit turned from a ₹2 crore loss to a ₹3 crore loss.

Valiant Laboratories Limited (VALIANTLAB) is a micro-cap Healthcare company valued at ₹731 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Valiant Laboratories Limited last traded at ₹134.65, sharply up 5.00% on the day.
Recent developments: On 2026-09-17, Valiant Laboratories Limited announced an acquisition agreement, which may expand its operations and product portfolio.
Financial performance: The company's annual revenue rose 78.5% year-over-year, but net profit turned from a ₹2 crore loss to a ₹3 crore loss. The latest quarter saw revenue jump 145.3% compared to the same quarter a year earlier, while net profit surged 955.0% to ₹21 crore.
Valuation multiples: The stock trades at 42.3 times earnings, a premium to the Healthcare median of 32.0, 2.18 times book value.
Things to watch: The company reported a net loss of ₹3 crore in its latest financial year, and its return on equity remains negative at -1.1%. The stock is 5.4% below its 52-week high, indicating a recent pullback from its peak.
Where it stands: Valiant Laboratories Ltd's latest quarter showed strong revenue and net profit growth, but its annual net profit loss widened. The stock is currently 5.4% below its 52-week high, and the company's return on equity remains negative.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

2.7/10

Poor

Fair Value

ROE

-1.05%

Weak

P/E

42.30x

Expensive

Debt / Equity

0.15

Low

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

Day₹125.25

₹134.65

52W₹49.51

₹134.65

DocStoX take

Supported by momentum (7.5), but held back by growth (1.0). Momentum looks strong at 7.5, but that is offset by growth at 1.0 and quality at 1.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

2.7

/10

Poor

Quality

Weak

ROE -1.1%

Valuation

Rich

P/E 42.3×

Growth

Flat

Revenue +5.5% 5Y CAGR

Risk

Moderate

D/E 0.15

Momentum

Strong

100% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹135

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹731 Cr

52W High / Low

₹135 / ₹50

Dividend Yield

0.00%

Promoter Holding

74.94%

EPS (TTM)

₹3.18

Book Value

₹57.24

Key highlights

Low leverage — D/E 0.15
Profit shrinking 41% a year
Loss-making in some of the last 5 years

1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Valiant Laboratories Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Valiant Laboratories Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Valiant Laboratories Limited with peers

Valiant Laboratories Limited vs Sun Pharmaceutical Industries Limited Valiant Laboratories Limited vs Divi's Laboratories Limited Valiant Laboratories Limited vs Torrent Pharmaceuticals Limited Valiant Laboratories Limited vs Apollo Hospitals Enterprise Limited Valiant Laboratories Limited vs Zydus Lifesciences Limited Valiant Laboratories Limited vs Laurus Labs Limited

Related tools & concepts

Value Valiant Laboratories Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

VALIANTLAB newsLatest coverage & filings Open screenerFilter the whole market